2015
DOI: 10.1089/jpm.2015.1032
|View full text |Cite
|
Sign up to set email alerts
|

Hypoglycemia Management in Nondiabetic Adults at the End of Life #291

Abstract: Hypoglycemia can be both an uncomfortable symptom and a life-limiting condition. In patients with altered mental status who have a fair to good functional capacity, this could significantly detract from their ability to enjoy life. There are a variety of treatment options, including corrective action and management of the side effects of the adrenergic discharge that should be considered, as long as they are consistent with the patient’s goals of care and comfort.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…This can be determined by administering a 1 mg intravenous glucagon stimulation test [19]. These recommendations have been summarized in fast fact format elsewhere [20].…”
Section: Management Strategiesmentioning
confidence: 99%
“…This can be determined by administering a 1 mg intravenous glucagon stimulation test [19]. These recommendations have been summarized in fast fact format elsewhere [20].…”
Section: Management Strategiesmentioning
confidence: 99%
“…Treatment is difficult; there is no general consent on the therapy in end-stage malignant diseases. Most authors describe 25 g of dextrose in 50 mL of fluid application, some add occasional glucagon shots, and corticosteroids are suggested as the last supportive measure [5]. As an alternative fuel source, even lipids were tested and encouraging but not definitive answers were given [6].…”
Section: Introductionmentioning
confidence: 99%
“…Treatment options include ''corrective'' strategies as well as supportive care focused on relieving the symptoms of hypoglycemia. 1 Although artificial nutrition and hydration typically have a limited role for symptom management, quality of life, or survival at the end of life, personal values and individual goals are paramount. 2 The decision to pursue continuous ambulatory infusion of dextrose solutions at the end of life should include careful consideration of the risks and feasibility of this heroic intervention if it is necessary to achieve a dying patient's goals.…”
mentioning
confidence: 99%